Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review

A Mazzariol, A Bazaj, G Cornaglia - Journal of Chemotherapy, 2017 - Taylor & Francis
Urinary tract infections (UTIs) are among the most frequent infectious diseases affecting
humans, and represent an important public health problem with a substantial economic …

Escherichia coli: an old friend with new tidings

J Vila, E Sáez-López, JR Johnson… - FEMS microbiology …, 2016 - academic.oup.com
Escherichia coli is one of the most-studied microorganisms worldwide but its characteristics
are continually changing. Extraintestinal E. coli infections, such as urinary tract infections …

Human and Avian Extraintestinal Pathogenic Escherichia coli: Infections, Zoonotic Risks, and Antibiotic Resistance Trends

M Mellata - Foodborne pathogens and disease, 2013 - liebertpub.com
Abstract Extraintestinal pathogenic Escherichia coli (ExPEC) constitutes ongoing health
concerns for women, newborns, elderly, and immunocompromised individuals due to …

Carbapenem-resistant Enterobacteriaceae in the community: a scoping review

AM Kelly, B Mathema, EL Larson - International journal of antimicrobial …, 2017 - Elsevier
Carbapenem antibiotics are used as a last resort to treat serious Gram-negative bacteria
(GNB) infections; however, carbapenemase-producing strains of GNB have emerged as a …

A review of ten years of the study for monitoring antimicrobial resistance trends (SMART) from 2002 to 2011

I Morrissey, M Hackel, R Badal, S Bouchillon… - Pharmaceuticals, 2013 - mdpi.com
Surveillance of antimicrobial agent resistance provides important information to guide
microbiologists and infectious disease specialists understanding of the control and the …

Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in south and southeast Asia

LY Hsu, A Apisarnthanarak, E Khan… - Clinical microbiology …, 2017 - Am Soc Microbiol
Carbapenem-resistant Gram-negative bacteria, in particular the Acinetobacter baumannii-
calcoaceticus complex and Enterobacteriaceae, are escalating global public health threats …

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of …

PNA Harris, PA Tambyah, DL Paterson - The Lancet Infectious …, 2015 - thelancet.com
The spread of extended-spectrum β-lactamase (ESBL) genes in Enterobacteriaceae such as
Escherichia coli or Klebsiella spp is a major challenge to modern medical practice …

[HTML][HTML] Morganella morganii, a non-negligent opportunistic pathogen

H Liu, J Zhu, Q Hu, X Rao - International Journal of Infectious Diseases, 2016 - Elsevier
Morganella morganii belongs to the tribe Proteeae of the Enterobacteriaceae family. This
species is considered as an unusual opportunistic pathogen that mainly causes post …

[HTML][HTML] A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated …

X Qin, BG Tran, MJ Kim, L Wang, DA Nguyen… - International journal of …, 2017 - Elsevier
Ceftazidime/avibactam comprises the broad-spectrum cephalosporin ceftazidime and the
non-β-lactam β-lactamase inhibitor avibactam. This phase 3, randomised, double-blind …

Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae

TM Ng, WX Khong, PNA Harris, PP De, A Chow… - PloS one, 2016 - journals.plos.org
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are a common
cause of bacteraemia in endemic countries and may be associated with high mortality; …